regulatoryinnovation
Description

Scientific technology for gene and cell therapy has made tremendous progress and the regulatory landscape is still developing. FDA and EMA have issued recommendations for gene therapies. Recent updates to the policy landscape will be discussed. Opportunities for harmonization will also be discussed.

Ability Level: Intermediate

Session ID: 503767

Tags